The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy.

Prostate Cancer Clinical Trial

— SHOR-TEST  

Official title:

The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy - a Randomized Controlled Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03675529
• Other study ID #: H-18020711
• Status: Completed
• Phase: N/A
• Start date: October 1, 2018
• Est. completion date: November 24, 2019

Study information

• Verified date: December 2019
• Source: Rigshospitalet, Denmark
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Background and purpose: The purpose of this study is to investigate the effect of one acute exercise bout on tumor hypoxia in patients with localized prostate cancer undergoing radical prostatectomy.

The primary hypothesis is that exercise reduces tumor hypoxia and that the reduction is greater in patients performing one acute high intensity exercise bout compared to no training controls.

The investigators have not been able to identify any prior or current randomized trials investigating exercise and tumor hypoxia, and believe that such research is warranted and would be of great importance. Moreover there is a need for studies including biological measurements to allow a full assessment of the effect of exercise on diverse biomarkers and mechanistic pathways, which may influence cancer survival.

Subjects: Patients with histologically verified prostate adenocarcinoma scheduled for radical prostatectomy at Urologic Department, Rigshospitalet, Copenhagen, Denmark.

Methods: In this randomized controlled pilot study 30 patients with localized prostate cancer undergoing radical prostatectomy will be included and randomized 2:1 to either one single acute High Intensity Interval Training bout or usual care and no training the day prior to radical prostatectomy.

All patients will undergo assessment at inclusion (baseline) and the day prior to surgery.

Assessment includes: anthropometrics; blood pressure; resting hearth rate; hip and waist circumference, ECG, quality of life by self-report questionnaires; fasting blood sample measuring PSA (prostate specific antigen), cholesterol, triglycerides, insulin, c-peptide, HbA1c, glucose and inflammatory markers.

All patients will receive one dose of pimonidazole hydrochloride (500 mg per m2 body surface) in order to quantify tumor hypoxia by pathological analyses after removal of the prostate.

Biological tissue from tumor (primary prostate biopsies) will also be retrieved from the respective local pathological departments and from the perioperative prostate specimen and sent to protocol analyses.

Description:

The purpose of this study is to investigate the effect of one acute exercise bout on tumor hypoxia in patients with localized prostate cancer randomized to one single acute I) High Intensity Interval Training bout compared to (II) usual care and no training prior to radical prostatectomy.

In addition to this the aim is to investigate the effect of one exercise bout on tumor vessel morphology and to investigate the effect of one acute exercise bout on intratumoral immune cell infiltration and to investigate the modulation of tumor-metabolism, -biology and signaling in patients randomized to either one acute High Intensity Interval Training bout compared to usual care and no training, the day prior to surgery.

Moreover this study will explore the acute response in immune cells, hormones and cytokines in blood samples taken before, during and after a single exercise session, and will collect physiological (metabolic profile and metabolic inflammatory markers) and psycho-social (e.g. fatigue, emotional well-being, anxiety) information regarding patients randomized to either one acute High Intensity Interval Training bout compared to usual care and no training, the day prior to surgery.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: November 24, 2019
• Est. primary completion date: November 24, 2019
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Men with histologically verified localized prostate adenocarcinoma undergoing curative intended radical prostatectomy.

Exclusion Criteria:

• Age: <18 years

• Any other known malignancy requiring active treatment

• Performance status > 1

• Allergy to pimonidazole

• Ongoing treatment with beta blockers

• Physical disabilities precluding physical testing and/or exercise

• Inability to read and understand Danish

Related Conditions & MeSH terms

• Hypoxia
• Prostate Cancer
• Prostatic Neoplasms

Intervention

Behavioral:
• High Intensity Interval Training bout
Patients randomized to the HIIT bout will perform one single supervised High Intensity Interval Training bout consisting firstly of a wattmax test on a stationary bike, in order to set the training intensity. This is followed by 10 minutes at low intensity at approximately 30% of wattmax. Subsequently patients will perform 16 min with 4 cycles with High and Low intensity. HI intervals consisting of 1 min with 100% of wattmax followed by 3 min recovery with the intensity load of 30% of wattmax.

Locations

Country	Name	City	State
Denmark	Center for Physical Activity Research, Copenhagen University Hospital	Copenhagen

Sponsors (1)

Lead Sponsor	Collaborator
Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Tumor hypoxia	Quantification of tumor hypoxia will be assessed using pimonidazole staining	At prostatectomy
Secondary	Intratumoral immune cell infiltration	Intratumoral immune cell infiltration will be quantified using histological analyses	Primary prostate biopsies and until radical prostatectomy
Secondary	Tumor vessel morphology	Tumor vessel morphology will be evaluated using histological analyses	Primary prostate biopsies and until radical prostatectomy
Secondary	Tumor metabolism-, biology and signaling	Tumor samples will undergo proteomic analyses in order to uncover potential upregulated biomarkers	Primary prostate biopsies and until radical prostatectomy
Secondary	Changes in immune cells during an acute exercise bout	Changes in immune cells during an acute exercise bout will be measured in blood samples using flowcytometry	From start of exercise bout and until 60 minutes post exercise
Secondary	Changes in epinephrine concentration	Concentration of epinephrine will be measured in blood samples by radioimmunoassay analyses.	From start of exercise bout and until 60 minutes post exercise
Secondary	Changes in nor-epinephrine concentration	Concentration of nor-epinephrine will be measured in blood samples by radioimmunoassay analyses.	From start of exercise bout and until 60 minutes post exercise
Secondary	Changes in various interleukines	Concentration of various interleukines will be measured in blood samples by measured in blood samples by Enzyme-Linked Immunosorbent Assay (ELISA) analyses.	From start of exercise bout and until 60 minutes post exercise
Secondary	Changes in Tumor Necrosis Factor alpha (TNFa) concentration	Concentrations of TNFa will be measured in blood samples by Enzyme-Linked Immunosorbent Assay (ELISA) analyses.	From start of exercise bout and until 60 minutes post exercise
Secondary	Changes in Interferon Gamma (IFN?) concentration	Concentrations of IFN? will be measured in blood samples by Enzyme-Linked Immunosorbent Assay (ELISA) analyses.	From start of exercise bout and until 60 minutes post exercise
Secondary	Concentration of C-reactive Protein (CRP)	Concentration of CRP will be measured in fasting blood sample by standard laboratory methods.	Blood sampling on the day of radical prostatectomy
Secondary	Total plasma cholesterol concentration	Concentrations of total cholesterol will be measured in fasting blood samples by standard laboratory methods.	Blood sampling on the day of radical prostatectomy
Secondary	Plasma LDL-Cholesterol concentration	Concentrations of LDL- cholesterol will be measured in fasting blood samples by standard laboratory methods.	Blood sampling on the day of radical prostatectomy
Secondary	Plasma HDL-Cholesterol concentration	Concentrations of HDL- cholesterol will be measured in fasting blood samples by standard laboratory methods.	Blood sampling on the day of radical prostatectomy
Secondary	Plasma triglyceride concentrations	Concentrations of triglycerides will be measured in fasting blood samples by standard laboratory methods.	Blood sampling on the day of radical prostatectomy
Secondary	HbA1C concentration	Concentrations of HbA1C will be measured in fasting blood samples by standard laboratory methods.	Blood sampling on the day of radical prostatectomy
Secondary	Plasma Insulin concentration	Concentrations of insulin will be measured in fasting blood samples by standard laboratory methods.	Blood sampling on the day of radical prostatectomy
Secondary	Plasma Glucose concentration	Concentrations of glucose will be measured in fasting blood samples by standard laboratory methods.	Blood sampling on the day of radical prostatectomy
Secondary	Wattmax-test	The participants in the HIIT group will undergo a maximal graded exercise test on a bicycle ergometer for evaluation of cardiovascular function and determination of the maximum watt (wattmax). The test starts with a 3 min warm up at 70 watt (the watts may have to be adjusted to the individual fitness level). Warm up is immediately followed by a 20 watt increase every 1 min until exhaustion. The maximum watt will be calculated.	At baseline assessment